Jennifer Domm - Concepedia

Author

Jennifer Domm

Vanderbilt University

Also Known As

J Domm, J. A. Domm, J. Domm, Jennifer A. Domm, Jennifer Ann Domm, Jennifer Domm

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Monroe Carell Jr. Children's Hospital Hospital for Sick Children Vanderbilt University Medical Center Fred Hutch Cancer Center

About

Jennifer Domm is an author at Vanderbilt University specializing in hematology, medicine, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	374
2	Health Sciences	5	5	121
3	Public Health	2	2	66
4	Allergy	1	1	18
5	Biomedical Engineering	1	1	37

Jennifer Domm

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia Haydar Frangoul, David Altshuler, Maria Domenica Cappellini, New England Journal of Medicine	2020	1.7K
Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants Simon Jones, Vassili Valayannopoulos, Eugene Schneider, Genetics in Medicine	2015	113
Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus Daniel E. Dulek, John V. Williams, C. Buddy Creech, Clinical Infectious Diseases VaccinationIntravenous ZanamivirViral BurdenAntiviral Drug DevelopmentAntiviral Therapy	2010	64
Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter Trial Lauri M. Burroughs, Eneida R. Nemecek, Troy R. Torgerson, Biology of Blood and Marrow Transplantation	2014	61
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders Lauri M. Burroughs, Akiko Shimamura, Julie‐An Talano, Biology of Blood and Marrow Transplantation	2017	50
Complications of central venous access devices in paediatric haemophilia patients Jennifer Domm, Margaret Hudson, Robert L. Janco Haemophilia ThrombosisVenous DiseaseVenous ThrombosisPediatric HematologyRetrospective Survey	2003	47
Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(d,l-lactide-co-glycolide) Mark Kreitz, Jennifer Domm, Edith Mathiowitz Biomaterials Membrane FormationMicroporous MembranesVitro DegradationMicro-encapsulationDrug Delivery Systems	1997	37
Targeted Busulfan therapy with a steady-state concentration of 600–700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant S. Maheshwari, Adetola A. Kassim, Rosa F. Yeh, Bone Marrow Transplantation Hematological MalignancyCell TherapyTransplantationSickle Cell DiseaseBone Marrow Transplant	2013	37
Preengraftment Syndrome after Unrelated Cord Blood Transplant Is a Strong Predictor of Acute and Chronic Graft-versus-Host Disease Haydar Frangoul, Li Wang, Frank E. Harrell, Biology of Blood and Marrow Transplantation Intensive Immune SuppressionStem Cell TransplantationHematologyClinical EpidemiologyGraft Survival	2009	36
Allogeneic Bone Marrow Transplantation for Chemotherapy-Refractory Hepatosplenic γδ T-Cell Lymphoma Jennifer Domm, M. Thompson, John F. Kuttesch, Journal of Pediatric Hematology/Oncology	2005	35

Page 1